Campbell & CO Investment Adviser LLC
Position in ABT — Abbott Laboratories
CIK 1353570
BALTIMORE, MD
Position in ABT
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$2,451,068
-$1,387,660 QoQ
Shares Held
27,012
-27.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,000
of 2,966 holders
Holding Since
Jun 2021
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Campbell & CO Investment Adviser LLC holds $33,000,533 across 20 Medical Devices names. ABT ranks #6 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | STE |
STERIS plc
|
29,009 | $6,108,425 | |
| 2 | BIO |
Bio-Rad Laboratories, Inc.
|
14,056 | $4,126,982 | |
| 3 | ENOV |
Enovis CORP
|
139,970 | $2,897,379 | |
| 4 | HAE |
Haemonetics Corp
|
36,844 | $2,763,300 | |
| 5 | IRTC |
iRhythm Holdings, Inc.
|
22,024 | $2,619,754 | |
| 6 | ABT |
Abbott Laboratories
This page
|
27,012 | $2,451,068 | |
| 7 | PODD |
Insulet Corp
|
12,102 | $1,842,529 | |
| 8 | EW |
Edwards Lifesciences Corp
|
17,148 | $1,551,208 |
All Filings in ABT
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,451,068 | 27,012 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $3,838,728 | 37,389 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,499,535 | 19,950 | Shares | Sole | 2026-02-12 | |
| 2025-03-31 | $1,080,036 | 8,142 | Shares | Sole | 2025-05-14 | |
| 2024-06-30 | $2,101,475 | 20,224 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $807,213 | 7,102 | Shares | Sole | 2024-05-10 | |
| 2023-03-31 | $1,343,618 | 13,269 | Shares | Sole | 2023-05-11 | |
| 2021-06-30 | $823,103 | 7,100 | Shares | Sole | 2021-08-11 | |
| No filing history on record for this holder in this stock. | ||||||